The histamine system, as all modulatory neurotransmitters, is a pleiotropic system. Histamine plays a major role in the regulation of autonomic functions, including energy balance, sleep, and regulation of body temperature. In addition, histamine is crucial in controlling arousal and cognition. The large array of functions regulated by histamine is mirrored by the widespread projections of histaminergic neurons, which are localized in the tuberomamillary nucleus in the hypothalamus and project widely throughout the brain ([@CIT0009]). Despite its important functions, the histaminergic system is much less studied compared with the more famous monoamine systems: noradrenaline, serotonin, and dopamine. This may have historical reasons; the Falck-Hillarp method that visualizes catecholamine ([@CIT0003]) and initiated the study of monoamines did not label histamine. Thus, the investigation of the histamine system lagged behind, and the study of histamine in the brain did not take until the development of an antibody against the synthesizing enzyme L-histidine decarboxylase ([@CIT0019]).

Another factor hampering the interest in the development of histaminergic drugs can be traced to histamine's regulation of sleep and the use of antihistamines to treat allergies. As everyone who used the old-generation antihistamine knows, these drugs make you drowsy, whereas stimulating the histamine system to improve, for example, cognition can entail sleep disturbances. Nevertheless, histamine has a great and underexplored potential to provide targets for many CNS disorders. The last years have seen an increase in the proposed use of histaminergic drugs beyond the homeostatic functions such as sleep and energy balance. The histamine system has been suggested as a possible target for the treatment of psychiatric disorders, and drugs that modulate this system have been especially proposed as cognitive enhancers ([@CIT0018]). An increased understanding of the histamine system should be of great use for the development of new, much-needed pharmacological treatments for psychiatric disorders.

The authors of a paper presented in this issue of IJNP previously showed that part of the hypophagic effect induced by oleoylethanolamide (OEA) is mediated by the histamine system ([@CIT0012]). OEA is released by the enterocytes in response to high fat intake and is known to reduce eating. OEA has also been shown to affect memory consolidation ([@CIT0002]), and the authors therefore asked the question whether histamine was also involved in this effect. Indeed, they showed that the administration of either H~1~ or H~2~ receptor antagonists in the amygdala blocked the effect of OEA in contextual fear conditioning.

There are 4 known histamine receptors expressed in the CNS, all of them G-protein coupled. The H~1~ and H~2~ receptors (Gq- and Gs-coupled, respectively) are classically considered postsynaptic receptors, whereas the H~1~ receptor activates the phospholipase C-phosphokinase C pathway and the H~2~ receptor activates the phosphokinase A pathway ([@CIT0010]). The H~3~ receptor is Gi-coupled and localized pre- and postsynaptically, whereas it has predominantly been studied as an autoreceptor. Blocking of the H~3~ receptor enhances histamine release that in turn modulates neuronal function and plasticity ([@CIT0006]; [@CIT0001]; [@CIT0007]) and has been proposed as a treatment of mental disorders ([@CIT0014]). The histamine H~4~ receptor was only recently discovered; it seems to have mainly immunological functions, and its distribution and function in the CNS are still somewhat debated ([@CIT0014]).

The fact that the effect of OEA on fear conditioning is completely abolished by blocking either the H~1~ or the H~2~ receptor in the amygdala is interesting. The overlapping effect of these 2 receptors has been seen in other areas and behaviors. Blocking either the H~1~ and H~2~ receptor in the lateral septum decreases anxiety ([@CIT0004]), and both the H~1~ and H~2~ receptor knockout mice show enhanced emotional learning but reduced spatial learning ([@CIT0005]). In other experiments, however, only the H~1~ receptor antagonist reduces anxiety, whereas the H~2~ receptor antagonist has no effect ([@CIT0008]). In the hippocampus, a H~2~ receptor antagonist, but not a H~1~ antagonist, improve learning ([@CIT0017]). The latter finding is at variance with the results of our study, where we needed to block both the H~1~ and the H~2~ receptor in the hippocampus to get an antidepressant effect in the forced swim test ([@CIT0007]). As [@CIT0012] discuss in their paper, there are many factors that can explain these differences, including differential expression of the H~1~ and H~2~ receptors in different areas, interaction with other neurotransmitter systems, and different roles of the H~1~ and H~2~ receptor in different behaviors. Their finding underscores our need to better understand the fundamental function of the H~1~ and H~2~ receptors in different areas in the central nervous system. Both the H~1~ and H~2~ receptors affect the excitability of neurons ([@CIT0020]; [@CIT0015]), and the H~1~ receptor can cause either membrane depolarization by reduction of leak potassium conductance or membrane hyperpolarization by intracellular calcium signaling and activation of calcium-activated potassium (K~Ca~) channels ([@CIT0008a]; [@CIT0019a]). The H~2~ receptor, on the other hand, inhibits the K~Ca~ channels that underlie afterhyperpolarization and affect firing pattern ([@CIT0008b]; [@CIT0010a]). Preliminary data from our laboratory (manuscript in preparation) show that evoked synaptic transmission is affected neither by neither the H~1~ nor the H~2~ receptor in the hippocampus, but that postsynaptic histamine receptors can affect spontaneous release of glutamate.

Taken in a larger perspective, the work of [@CIT0012] is also a reminder that we cannot consider the brain in isolation. The brain is in itself a complex organ, where several neurotransmitters interact, such as the noradrenergic and histaminergic systems, as shown by the authors. In addition, we need to consider the interaction between the brain and the periphery. Since it is well known that our body-state affects our behavior and cognition, it is promising that we now start to identify the signaling pathways from the periphery to the central nervous system. The work from [@CIT0012], together with others ([@CIT0011]), is an important contribution to this endeavor, where they identify that OEA released from enterocytes activates the vagus nerve, the trigeminal tract, which in turn affects several neuromodulatory systems, including histamine ([@CIT0012]). In the ongoing work on peripheral signals affecting higher cognitive functions, such as memory, we have a lot to learn from the work already done in studies of autonomic functions ([@CIT0016]).

The identification of signaling pathways connecting the periphery with the central nervous system is fascinating and holds great promise for the development of new therapeutics, since the periphery is much more accessible for pharmaceutical treatment compared with the brain.
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